ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,485
-0,48%
Bitcoin
59 579,60
-1,68%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Dare Bioscience Inc (DARE)

  7. Dare Bioscience Inc (DARE) Actualités

DARE Dare Bioscience Inc

0,319
0,0371 (13,16%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Dare Bioscience Inc DARE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0371 13,16% 0,319 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,28 0,28 0,3904 0,3075 0,2819
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202413:30GLOBEDaré Bioscience Secures $22 Million in Non-Dilutive..
23/4/202414:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
11/4/202414:00GLOBEDaré Bioscience Announces Publication in Contraception of..
28/3/202413:00GLOBEDaré Bioscience Reports Full Year 2023 Financial Results and..
28/3/202412:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
21/3/202413:00GLOBEDaré Bioscience to Host Full Year 2023 Financial Results and..
22/2/202414:00GLOBEDaré Bioscience to Present at the International Society for..
31/1/202414:00GLOBEDaré Bioscience Announces Positive End-of-Phase 2 Meeting..
29/1/202422:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/1/202423:15EDGAR2Form 8-K - Current report
26/1/202422:30GLOBEDaré Bioscience Announces Executive Team and Board of..
19/1/202422:30EDGAR2Form 8-K - Current report
17/1/202414:00GLOBEDaré Bioscience Announces Grant to Support Biotherapeutic..
08/1/202414:00EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEDaré Bioscience’s DARE-LARC1 Platform Technology Achieves..
26/12/202314:05EDGAR2Form 8-K - Current report
26/12/202314:00GLOBEDaré Bioscience Secures $12 million in Royalty-backed..
20/12/202314:05EDGAR2Form 8-K - Current report
20/12/202314:00GLOBEDaré Bioscience Announces Positive Topline Pharmacokinetic..
13/12/202314:00GLOBEDaré Bioscience Announces Funding Award Notice from the..
07/12/202314:00GLOBEDaré Bioscience Announces FDA Clearance of Investigational..
04/12/202314:00GLOBEDaré Bioscience Announces Commencement of Phase 3 Study of..
20/11/202314:00GLOBEDaré Bioscience and Premier Research Extend Strategic..
13/11/202314:00GLOBEDaré Bioscience to Present at the Sexual Medicine Society of..
09/11/202323:15EDGAR2Form 8-K - Current report
09/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEDaré Bioscience Reports Third Quarter 2023 Financial Results..
06/11/202314:00GLOBEDaré Bioscience to Participate in Three November Conferences
02/11/202313:00GLOBEDaré Bioscience to Host Third Quarter 2023 Financial Results..
01/11/202313:05EDGAR2Form 8-K - Current report
01/11/202313:00GLOBEDaré Bioscience Announces Additional Positive Data from..
16/10/202314:15EDGAR2Form 8-K - Current report
16/10/202314:00GLOBEDaré Bioscience Announces Achievement of First Commercial..
21/9/202314:00GLOBEDaré Bioscience Announces Grant Funding Installment to..
20/9/202314:00GLOBEDaré Bioscience to Present at The Menopause Society 2023..
11/9/202314:15EDGAR2Form 8-K - Current report
06/9/202314:00GLOBEDaré Bioscience to Participate in Upcoming Investor..
05/9/202314:00GLOBEDaré Bioscience Completes Previously Announced Equity..
30/8/202323:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/8/202322:05EDGAR2Form 8-K - Current report
30/8/202314:00GLOBEDaré Bioscience Announces $7.0 Million Registered Direct..
10/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:05EDGAR2Form 8-K - Current report
10/8/202314:00GLOBEDaré Bioscience Reports Second Quarter 2023 Financial..
09/8/202314:00GLOBEDaré Bioscience Announces Publication in The Journal of The..
03/8/202314:00GLOBEDaré Bioscience to Host Second Quarter 2023 Financial..
31/7/202314:00GLOBEDaré Bioscience Announces Grant Award Supporting Development..
21/7/202322:01EDGAR2Form 8-K - Current report
11/7/202323:30GLOBEDaré Bioscience to Present at the 9th Annual International..

Dernières Valeurs Consultées

NASDAQ
DARE
Dare Bioscience
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés